Close Menu
Fund Focus News
    Facebook X (Twitter) Instagram
    Trending
    • Is your mutual fund sitting on too much cash? Experts explain what the cash level actually tells you
    • Will you pay lower income tax on mutual fund capital gains after retirement? Know 7 ways to reduce your tax burden
    • 5 Best-Performing Equity Mutual Funds in August 2026 – Industry News
    • Investing in a popular mutual fund? 5 things to check beyond AUM and past returns
    • MF return vs investor reality: Small-cap funds gain 15%, but investors lose money. Here’s how
    • Small-cap mutual funds shine: These schemes led the six-month rally
    • Bitcoin ETFs erase most of their 2026 losses, with $1B left to go
    • CI Global Asset Management Announces Risk Rating Change for CI Floating Rate Income Fund
    Facebook X (Twitter) Instagram
    Fund Focus News
    • Home
    • Bonds
    • ETFs
    • Funds
    • Investments
    • Mutual Funds
    • Property Investments
    • SIP
    Fund Focus News
    Home»Mutual Funds»HDFC Pharma & Healthcare Fund Delivers 30.19% CAGR, Scheme Bets On India’s Expanding Healthcare Sector
    Mutual Funds

    HDFC Pharma & Healthcare Fund Delivers 30.19% CAGR, Scheme Bets On India’s Expanding Healthcare Sector

    September 8, 2026


    Mumbai: has highlighted the performance of its HDFC Pharma and Healthcare Fund, which delivered a compound annual growth rate of 30.19 percent since its launch on October 4, 2023.

    The sectoral fund also generated a one-year return of 19.01 percent as of July 31, 2026. Its net asset value stood at Rs 21.069 on the same date.

    Where does the fund invest?

    The scheme aims to generate long-term capital appreciation by investing mainly in equity and equity-related instruments of pharmaceutical and healthcare companies.

    Its portfolio covers , healthcare service providers, biotechnology, medical equipment and supplies. The fund follows a research-led, bottom-up investment approach and can invest across companies of different market capitalisations.

    Nikhil Mathur manages the HDFC Pharma and Healthcare Fund.

    Healthcare growth opportunity

    HDFC Mutual Fund said India’s pharmaceutical and healthcare industry offers a structural growth opportunity, supported by rising domestic demand, increasing healthcare expenditure and expanding export opportunities.

    India’s position as a major global pharmaceutical manufacturing centre is also expected to support the sector’s long-term prospects.

    The fund house sees opportunities in complex generic medicines, biosimilars, speciality drugs, contract development and manufacturing, hospitals, diagnostics and medical technology.

    Long-term trends support demand

    An ageing population, the growing incidence of lifestyle-related diseases, rising per capita income and increasing health insurance penetration could further boost healthcare spending in India.

    HDFC AMC Managing Director and Chief Executive Officer Navneet Munot said the fund house remains focused on identifying businesses that are well placed to benefit from these long-term trends.

    However, investors should note that sectoral and thematic schemes carry higher risks than diversified equity mutual funds because their investments are concentrated in a particular sector or theme.

    Past performance may not continue in the future and does not guarantee future returns. Investors should carefully assess their risk appetite and financial goals before investing.




    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

    Related Posts

    Is your mutual fund sitting on too much cash? Experts explain what the cash level actually tells you

    September 9, 2026

    Will you pay lower income tax on mutual fund capital gains after retirement? Know 7 ways to reduce your tax burden

    September 9, 2026

    5 Best-Performing Equity Mutual Funds in August 2026 – Industry News

    September 8, 2026
    Leave A Reply Cancel Reply

    Top Posts

    Is your mutual fund sitting on too much cash? Experts explain what the cash level actually tells you

    September 9, 2026

    Will you pay lower income tax on mutual fund capital gains after retirement? Know 7 ways to reduce your tax burden

    September 9, 2026

    Bitcoin ETFs erase most of their 2026 losses, with $1B left to go

    September 8, 2026

    5 Best-Performing Equity Mutual Funds in August 2026 – Industry News

    September 8, 2026
    Don't Miss
    Mutual Funds

    Is your mutual fund sitting on too much cash? Experts explain what the cash level actually tells you

    September 9, 2026

    A rise in a mutual fund’s cash allocation can easily be mistaken for a warning…

    Will you pay lower income tax on mutual fund capital gains after retirement? Know 7 ways to reduce your tax burden

    September 9, 2026

    5 Best-Performing Equity Mutual Funds in August 2026 – Industry News

    September 8, 2026

    Investing in a popular mutual fund? 5 things to check beyond AUM and past returns

    September 8, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    EDITOR'S PICK

    Despite very strong P&C results and Investments performances, SCOR posts a EUR -308 million net loss in Q2 2024 (EUR -112 million net loss in H1 2024), driven by the 2024 L&H assumption review

    July 30, 2024

    Mutual funds take to factor-based investing; bridging active, passive gap | Mutual Fund – Top Stories

    August 26, 2024

    NS&I raises interest rates on British Savings Bonds

    November 7, 2025
    Our Picks

    Is your mutual fund sitting on too much cash? Experts explain what the cash level actually tells you

    September 9, 2026

    Will you pay lower income tax on mutual fund capital gains after retirement? Know 7 ways to reduce your tax burden

    September 9, 2026

    5 Best-Performing Equity Mutual Funds in August 2026 – Industry News

    September 8, 2026
    Most Popular

    🔥Juve target Chukwuemeka, Inter raise funds, Elmas bid in play 🤑

    August 20, 2025

    💵 Libra responds after Flamengo takes legal action and ‘freezes’ funds

    September 26, 2025

    🇮🇸 CPP Investments and Equinix complete atNorth acquisition to support growth of leading Nordic data center platform

    September 1, 2026
    © 2026 Fund Focus News
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions

    Type above and press Enter to search. Press Esc to cancel.